Effects of Estrogen on Glucose Uptake by Rat Muscle 1 by Shamoon, Harry & Felig, Philip
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 47, 227-233 (1974)
Effects of Estrogen on Glucose Uptake by Rat Muscle1
HARRY SHAMOON2 AND PHILIP FELIG
Departtenit of Internlal Medicine, Yale University Schlool of Mcdicine,
New Haven, Conlzlecticlut 06510
Received Junie 16, 1974
The isolated rat diaphragm was used to study the effects of 17,/-estradiol on basal
and insulin-mediated glucose uptake. Rats were injected with estradiol for 2 wk in
daily doses of 10 ,ug/ 100 g of body weight and were compared to untreated control
animals. Estrogen treatment resulted in a 16% decrease in basal glucose uptake by
diaphragm muscle as compared to controls. In contrast, in the presence of insulin,
glucose uptake by muscle increased 103% above basal in estradiol-treated animals
as compared to a 38% rise in the control group. The absolute rate of glucose uptake
induced by insulin in the estradiol treated animals (5.8 mg/g/hr) was 22% higher
than in controls. These findings were not accompanied by changes in weight gain,
plasma glucose and plasma immunoreactive insulin concentrations in the treated ani-
mals. Int vitro incubation of diaphragm mtiscle with estradiol did not have an effect
on basal or insulin-mediated glucose uptake.
The data indicate that treatment with naturally occLurring estrogens increases mus-
cle sensitivity to insulin-stimulated glucose uptake. These findings suggest that the
carbohydrate intolerance associated with the administration of oral contraceptives
may be related to the use of synthetic rather than natural estrogens and/or progestins
in such preparations.
INTRODUCTION
Early attempts at understanding the interaction of sex steroids and carbohydrate
metabolism showed that crude estrogenic preparations decreased glycosuria in dia-
betic animals (1). Subsequent reports were contradictory, but it was clear that
the effects of estrogens on carbohydrate metabolism varied in relation to the animal
model employed, the steroid preparation administered, and the doses used (2).
Our interest in this subject was prompted by the observation that the administration
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of oral contraceptive agents is associated with a deterioration in glucose tolerance
in 20-70% of women taking these agents (2, 3). Whether the diabetogenic effects
of oral contraceptives are a consequence of the presence of synthetic rather than
natural estrogens or are related to their progestin content has not been established
(4). The present investigation was consequently carried out to determine if estro-
gen, specifically the naturally occurring 17,8-estradiol, affects basal and insulin-
stimulated glucose uptake by muscle cells. In this study, the isolated rat diaphragm
technique (5) was employed to evaluate the interaction of estrogen and insulin on
glucose uptake by muscle.
MATERIALS AND METHODS
Non-pregnant, adult, female rats of the Wistar strain (Camm Research, Wayne,
NJ) were used in all the experiments. Animals were kept in individual cages for at
least 10 days prior to the experiment. Food and water were allowed ad lib., the
diet consisting of Purina Laboratory Chow. Room temperature was kept at 75-800F
with lighting from 6:00 A.M. until 6:00 P.M. Weight gain ranged from 15-25
g/wk; animals weighed 120-180 g at the time of study. In order to reduce diurnal
variations, all rats were sacrificed between 8:00 and 10:00 A.M. on the day of
the study.
Animals were fasted for 24 hr prior to the morning of the experiment but were
allowed access to water. Rats were decapitated using a guillotine (Harvard Appa-
ratus) following which the diaphragm was removed (6). After excision, the tissue
was placed in 5 ml of iced Krebs-Ringer bicarbonate buffer (pH 7.4) saturated
with 95% 02/5% C0O. The muscle was then trimmed and divided into two or four
equal portions yielding hemi- and quarterdiaphragms, respectively. The latter were
then preincubated at room temperature for 10 min in 10 ml of buffer containing
glucose (150 mg/100 ml) to allow equilibration of the muscle (7). At the end
of prencubation, each piece of muscle was transferred to a 10cc Erlenmeyer flask
containing 1.0 ml of buffer to which glucose was added in a concentration of 150
mg/100 ml and 1% bovine serum albumin (BSA). The effect of insulin was stud-
ied by adding insulin in a concentration of 100 IU/ml to some of the flasks. The
flasks were gassed with 95% 0.,/5% CO., sealed, and incubated at 37°C in a Dub-
noff metabolic shaking bath at 100 oscillations/min for 60 min.
Glucose concentrations were measured initially and at the end of the incubation
period in duplicate. Each piece of diaphragm was weighed at the end of incubation
and glucose uptake could thus be expressed as milligrams of glucose per gram wet
muscle per hour (mg/g/hr).
Since blood was not obtainable from decapitated rats, samples for glucose and
immunoreactive insulin (IRI) levels were obtained in 10 animals by vena caval
puncture under ether anesthesia.
Two groups of animals were studied to determine the effect of in vivo administra-
tion of estrogen on glucose uptake. Group I consisted of control animals injected
subcutaneously with sesame oil (0.08-0.12 ml) daily for 2 wk. GroupII rats were
treated, with 17,3-estradiol in a dose of 10 ug per 100 g body weight per day in
a similar fashion as controls. This dose was chosen to achieve circulating estrogen
concentrations sufficient to inhibit ovulation (8). For each animal in both groups,
one hemidiaphragm was incubated with insulin and the other without insulin.
Additional studies were conducted on a separate group of uninjected animals
to determine the effects of in vitro addition of estrogen on glucose uptake. Dia-
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phragms were divided into four equal portions. In each animal, one quarter-dia-
phragm was incubated in a control flask containing glucose (150 mg/100 ml) and
BSA (1 % ) in buffer, and the others were incubated with insulin (100 Uunits/ml)
and/or estradiol. The concentration of estradiol in the flasks was 500 pg/ml
(2 X 10-3 UM) which is in excess of the peak plasma concentrations of 30 pg/ml
observed in adult female Wistar rats (9).
In an additional set of experiments, quarterdiaphragms were pre-incubated with
estradiol for 10 min at a concentration of 2 umoles/liter and then added to flasks
as described above.
The use of quarterdiaphragms allowed each animal to act as its own control,
thus facilitating the statistical analysis as well as eliminating interanimal variability.
Insuiln used was crystalline zinc insulin (Lilly, U100 Regular Insulin, Lot
#2L13854) diluted in veronal buffer (barbital/Na diethylbarbiturate 0.02 M)
containing 2% BSA. 17,8-estradiol (estra-1 3"5 '0°-triene-3,17-diol) was A Grade
chromatographically pure steroid (California Biochemical Corp., Lot #201120).
Dilutions were carried out in reagent grade ethanol followed by serial dilution in
distilled water.
Glucose determinations were carried out by the glucose oxidase method (10)
using the Glucostat Reagent Kit (Worthington Biochemical Corp., Freehold, NJ)
with modifications (11).
Due to the large numbers of comparisons, a simple t test for significance was
not appropriate. Hence, all experiments were initially analyzed according to a re-
peated measures analysis of variance design (12). Where an amnibus F test in
the Anova proved to be significant, differences between means of individual groups
were tested for significance using the Newman-Keuls procedure for evaluating q,
the studentized range statistic, where q = (x2 - xi)/(s.e.),.
RESULTS
In Vivo Studies
The effects of estradiol administration on glucose uptake by rat hemidiaphragms
is shown in Table 1. Estrogen treatment resulted in a 16% decrease in basal glucose
uptake as compared to control (P < 0.001). In both groups insulin resulted in
a significant increase in glucose uptake above basal (P < 0.001). However, the
absolute rate of glucose uptake in the presence of insulin in the group receiving
estrogen was 22% higher than in controls (P < 0.001). This effect of estrogen
on insulin-stimulated glucose uptake is even more evident when the change in glu-
cose uptake as compared to the basal state is examined. The increment in glu-
cose uptake induced by insulin in control animals was 1.33 ± 0.06 mg/g/hr
TABLE 1
EFFECT OF ESTRADIOL TREATMENT ON GLUCOSE UPTAKE BY HEMIDIAPHRAGMS
(MEAN ± SEM)
Glucose uptake (mg/g/hr)
N Control Estradiol P
Basal (no insulin) 19 3.49 ± 0.06 2.91 ± 0.06 <0.001
Insulin (100 Am units/ml) 19 4.82 ± 0.06 5.88 ± 0.06 <0.001
P <0.001 <0.001
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FIG. 1. Effect of estrogen (estradiol) on insulin-stimulated glucose uptake by rat diaphragm.
The height of the bars represents the mean (+SEM) change in glucose uptake above basal
levels induced by insulin in control (open bar) and estradiol-treated (hatched bar) animals.
(mean +SEM) whereas in estradiol-treated rats the increment was 2.97 0.06
mg/g/hr (P < 0.001) (Fig. 1).
These changes representing an increase in uptake of 38% above basal in the
control animals as compared to a 103% increase above basal levels in estradiol-
treated animals.
In Table 2 the body weights and concentrations of plasma glucose and insulin
are shown. There were no significant differences with respect to body weights,
plasma glucose or immunoreactive insulin concentrations after 2 wk of treatment
with estrogen as compared to controls.
In Vitro Studies
In Table 3, the effect of in vitro addition of estradiol to rat quarterdiaphragms
is shown. In the initial set of pilot experiments (Expt A) insulin addition was
found to increase glucose uptake from 2.65 0.22 mg/g/hr in the basal state to
4.33 0.38 mg/g/hr (P < 0.001). The addition of estradiol (2 X 10-3 MAM)
in vitro had no effect on basal glucose uptake (Expt B). In Expt C, the in vitro
addition of estradiol is shown to have no effect on insulin-stimulated uptake of glu-
cose. In the final group of rats (Expt D), quarterdiaphragms from each animal
were preincubated at 2 FM concentrations of estradiol prior to the usual incuba-
tion. Glucose uptake with insulin treatment was again significantly greater than
TABLE 2
FASTING PLASMA GLUCOSE, IMMUNOREACTIVE INSULIN (IRI) AND BODY WEIGHTS IN
CONTROL AND ESTRADIOL-TREATED RATS (MEAN ± SEM)
Glucose IRI Weight
N (mg/100 ml) (,um units/ml) (g)
Control 5 99.2 ± 3.7 34.0 ± 2.8 155 ± 8.3
Estradiol-treated 5 97.6 ± 3.9 33.8 ± 2.9 158 ± 5.92
Significance (P) *
* By Student's t test.ESTROGEN AND GLUCOSE UPTAKE
'TABLE 3
GL,UTCOSE UPTAKEl (MEAN + SEM1) BY Ql EATTIcnIt)l ADEIs TREATED UNDER
VAIRYING CONDITIONS IN XITIRO
ITreatmeneiit COII(litiOii
Insnlin aIl(l
. Control Inisulill Estraliol estra(lio'
IExptA 1() . 65 0.3 4.33 + 0.38
L'xpt 13 B 3.59 ± 0.38 3.53 + OA$)
E'xpt (C -3 3.74 ± 5.>2 b5*5 + 0..7 b'5A-8 + O.0'6
cExpt l) 9 3.2 + 0. b.1 66 + 0. 1() h4.6() ± 0.8
a Significanitly different fronii conitrol (P < 0.01).
bSignificantly differ-enit fromii conitrol (P < 0.05).
c In Expt 1), all quarterdiaphragnins wer-e preineubate(l withI estrogeni for 10 min in a concentration
of 2 ,unioles/liter.
control (4.66 ± 0.19 vs 3.22 + 0.26 mg/g/hr), but preincubation followed by
incubation with estradiol and insulin was associated with no change as compared
to insulin alone.
Since the estradiol was dissolved in ethanol, the effect of ethanol addition (0.1 %
by volume) on insulin-stimulated glucose uptake was also examined in 10 rats.
Glucose uptake in control flasks was 4.16 ± 0.31 mg/g/hr; in flasks containing
insulin the uptake was 5.79 ± 0.36 mg/g/hr (P < 0.05) and in flasks containing
insulin plus ethanol the uptake was 5.69 ± 0.40 mg/g/hr. This represented no
significant difference from insulin treatment alone.
DISCUSSION
The discovery that anterior pituitary extract was diabetogenic in the rat and
that hypophysectomy ameliorated the diabetic state (13) prompted studies of the
effects of estrogen on carbohydrate metabol'sm. Crude estrogenic preparations
were found to decrease glycosuria in diabetic animals (1, 14), yet could also exac-
erbate diabetes (15, 16). Houssay and his associates showed that the incidence
of diabetes following subtotal (95% ) pancreatectomy in male rats was 100% in
6 mo but only 20% in female rats (16). The "protective" effect of the female
sex hormones was also suggested by studies in which castration followed pancrea-
tectomy (17) and by the demonstration that exogenously administered estrogens
reduced the incidence of diabetes after pancreatectomy, especially in the male (18).
In humans evidence regarding the effect of sex steroids on carbohydrate metab-
olism has been accumulated since the advent of oral contraceptive agents. In
women treated with a synthetic estrogen-progestin combination, as many as 75%
developed abnormalities in oral glucose tolerance testing (19). Subsequent studies
suggested that the agent responsible for this deterioration in carbohydrate tolerance
was the estrogenic component (2, 3).
Our studies demonstrate that short-term administration of the naturally-occurring
17,8-estradiol in doses approximating those in oral contraceptives, results in sig-
nificantly greater insulin-mediated uptake of glucose by skeletal muscle. These find-
ings are thus compatible with previous data demonstrating that estrogens have a
protective effect on the development of diabetes. However, the mechanism postu-
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lated by the earlier studies, namely that estrogens increased endogenous insulin
secretion (13, 17, 18) is not borne out by our findings (Table 2). In our animals,
there were no changes in immunoreactive insulin concentrations, indicating that
hyperinsulinemia is not a consequence of estrogen treatment nor a prerequisite
for improved glucose uptake by peripheral tissue. The current data suggest that
estrogens increase the sensitivity of skeletal muscle to insulin-stimulated glucose
uptake. This enhanced response can account for improvement of the diabetic state
in partially pancreatectomized animals since small amounts of endogenous insulin
are likely to be secreted by the pancreatic remnant.
The current data challenge the notion that all estrogens are diabetogenic (2,
3). It should be noted, however, that recent studies indicate that only synthetic
estrogens, particularly when combined with 19-nortestosterone progestins, cause a
deterioration in glucose tolerance (4). In contrast, natural estrogens fail to dem-
onstrate this effect (20). Our data support the validity of these conclusions in that
the naturally-occurring estrogen, 17,8-estradiol, was found to increase rather than
decrease insulin sensitivity in muscle. In addition, the data suggest that the impair-
ment of carbohydrate tolerance with pregnancy cannot be ascribed to estrogen but
is probably a consequence of other gestational hormones.
In order to determine if the effects of in vivo administration of estrogen involved
a direct hormonal interaction at the tissue level, in vitro incubations with estradiol
plus insulin were conducted. We found that even at supranormal concentrations
of 17,8-estradiol, there were no changes in basal or insulin-mediated glucose uptake.
In addition, there was no evidence that other factors (i.e., ethanol diluent) could
be interfering. Preincubation with estradiol demonstrated that even with periods
exceeding 10 min there was no direct effect of estrogen on skeletal muscle uptake
of glucose. This insensitivity of muscle to incubation with estrogens may reflect
the fact that under physiologic circumstances rat diaphragm muscle fails to accu-
mulate estrogens in a manner comparable to uterine muscle (21).
As contrasted to the action of insulin, we found that estrogen treatment was
associated with a 16% decrease in basal glucose uptake as compared to control.
The failure of this change in glucose uptake to be reflected in alterations in the
fasting plasma glucose concentrations is explainable when one considers the relative
contribution of resting muscle to total systemic glucose turnover. In the postab-
sorptive state the vast bulk of circulating glucose is taken up by non-insulin-
dependent tissues (brain, nerve, blood cells) with muscle depending largely on fatty
acids and ketone bodies as sources of energy. Even when glucose, insulin and fatty
acids are present in greater concentrations (e.g., after a meal), glucose accounts
for as little as one-fifth of the oxidative metabolism of resting muscle (22). Thus,
a relatively large change in uptake of glucose by resting muscle in the fasted state
would not perceptibly affect blood glucose levels.
It is noteworthy that while estrogen had opposing effects on basal and insulin-
stimulated glucose uptake, these actions may be interrelated. In the intact animal,
a two- to threefold increase in the sensitivity of diaphragm muscle to insulin would
result in an increased pool of intracellular glycogen (by increasing availability of
glucose and/or induction of enzymes). When removed from the animal, muscle
metabolism becomes wholly dependent on intracellular stores of energy. Thus mus-
cle from estrogen-treated animals, having a higher content of glycogen, would be
expected to have a relatively smaller need for exogenous glucose. A consequent
decrease in basal glucose uptake may thus be explained.
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